Efficacy of Digital CBT-I Utilizing Embodied Artificial Intelligence Agent in Virtual Reality

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this clinical trial is to evaluate whether a virtually embodied artificialintelligence (AI) agent delivered via VR‐enhanced digital cognitive behavioral therapyfor insomnia (dCBT‐I) can improve insomnia outcomes and treatment adherence in adultswith insomnia.The main questions it aims to answer are:‐ Does VR‐enhanced dCBT‐I with an embodied AI agent lead to greater improvements ininsomnia symptoms compared to app‐based dCBT‐I with an AI chatbot at post‐interventionand 3‐month follow‐up?Researchers will compare VR‐enhanced dCBT‐I with an embodied AI agent to app‐based dCBT‐Iwith an AI chatbot to see if the VR‐enhanced intervention results in significantlyimproved clinical outcomes and adherence.Participants will: ‐ Be randomly assigned to either the VR‐enhanced AI agent intervention group or theapp‐based AI chatbot control group ‐ Complete a digital cognitive behavioral therapy for insomnia (dCBT‐I) program witheither a virtually embodied AI agent (VR‐based) or a chatbot‐based application ‐ Undergo assessments at baseline, post‐intervention, and 3‐month follow‐up
Epistemonikos ID: 0adc5254d3ade4cf45ffe3573b93ad33bf742a7b
First added on: Jul 14, 2026